This compound is a salt form of a benozazepine-based primary amine, typically supplied as a pharmaceutical intermediate. Its structure consists of a tricyclic amine core and a fumaric acid counterion, indicating use in research or manufacturing settings.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
6-Aminomethyl-6,11-dihydro-5H-dibenz[b,e]azepine (E)-2-butenedioate
pharmaceutical intermediate
(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethanol
pharmaceutical intermediate
(S)-4-Chloro-3-hydroxybutyronitrile
pharmaceutical intermediate
Methyl 1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-alpha-D-glucopyranoside
pharmaceutical intermediate
Ethyl 3-(nitromethyl)hexanoate
pharmaceutical intermediate
(E)-but-2-enedioic acid;6,11-dihydro-5H-benzo[c][1]benzazepin-6-ylmethanamine
IUQYGXGUFNMQGL-WLHGVMLRSA-N
C1C2=CC=CC=C2C(NC3=CC=CC=C31)CN.C(=C/C(=O)O)\C(=O)O
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.